Who owns the IMPLAVAX trademark?

The IMPLAVAX trademark is owned by Enesi Pharma Limited.

What is the serial number for IMPLAVAX?

The USPTO serial number for IMPLAVAX is 79233134.

What is the registration number for IMPLAVAX?

IMPLAVAX is registered under USPTO registration number 5706102.

IMP

USPTO Trademark Record

ABANDONED

IMPLAVAX

Q: What class is the IMPLAVAX trademark registered in?

The IMPLAVAX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

SN 79233134·Reg 5706102·Filed Mar 20, 2018

Owner Enesi Pharma Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

IMPLAVAX (Serial No. 79233134), Registration No. 5706102, is a abandoned US trademark filed on Mar 20, 2018 by Enesi Pharma Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

Mark Intelligence

IMPLAVAX (Reg. #5706102) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 20, 2018

SERIAL

79233134

REG#

5706102

REGISTERED

Mar 26, 2019

Owner

Applicant

Enesi Pharma Limited

Entity

Not Provided

Address

120 A&B Olympic Avenue,, Milton Park Abingdon, Oxfordshire OX14 4SA

Country

Attorney

NameRebecca A Liebowitz

Law firm

Rebecca A Liebowitz VENABLE LLP

Docket

60895-436618

Address

P.O. Box 34385, Washington, DC 20043-9998, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 20, 2018

Serial Number79233134

Registration No.5706102

Registration DateMar 26, 2019

Status DateOct 10, 2025

Published for OppositionJan 08, 2019

Mark TypeStandard characters

Attorney Docket60895-436618

Status DescriptionDead and cancelled, Section 71

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

35 events

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Jun 10, 2026

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

CANCELLED SECTION 71

Oct 10, 2025

CANCELLED SECTION 71

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Mar 26, 2024

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

COUNTERCLAIM OPP. NO. 999999

Jun 04, 2020

COUNTERCLAIM OPP. NO. 999999

NEW CERTIFICATE UNDER SECTION 7 - PROCESSED

Jan 03, 2020

NEW CERTIFICATE UNDER SECTION 7 - PROCESSED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 09, 2019

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 7 REQUEST RECEIVED

Nov 05, 2019

TEAS SECTION 7 REQUEST RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Oct 03, 2019

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 16, 2019

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 30, 2019

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 30, 2019

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 26, 2019

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 26, 2019

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jan 08, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 08, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 19, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 14, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 01, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Oct 31, 2018

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 31, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

FINAL REFUSAL WRITTEN

Oct 03, 2018

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 03, 2018

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 03, 2018

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 25, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 25, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 25, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jul 27, 2018

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 12, 2018

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 12, 2018

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 03, 2018

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jul 02, 2018

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jun 29, 2018

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jun 12, 2018

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 07, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

May 31, 2018

SN ASSIGNED FOR SECT 66A APPL FROM IB

IMPLAVAX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Enesi Pharma Limited

Other Marks by Rebecca A Liebowitz

Resources

Company